Decarbonization Plus Acquisition Corporation IV $275 million IPO
We advised the underwriters on the SPAC IPO and Nasdaq listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Cyteir Therapeutics $133.2 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Molecular Partners $64 million IPO
We advised the joint book-running managers and underwriters on the IPO and Nasdaq listing
Nayax ILS 767 million IPO
We advised Nayax on its IPO and listing on the Tel Aviv Stock Exchange
Decarbonization Plus Acquisition Corporation III $350 million IPO
We advised the underwriters on the SPAC IPO and Nasdaq listing
Paya Holdings $245 million stock offering
We advised the underwriters on the SEC-registered equity offering
Kadem Sustainable Impact $175 million IPO
We advised the book-running manager on the SPAC IPO and Nasdaq listing
Crown PropTech Acquisitions $276 million IPO
We advised the SPAC on its IPO and NYSE listing
Decarbonization Plus Acquisition Corporation II $402.5 million IPO
We advised the underwriters on the SPAC IPO and Nasdaq listing
CureVac $450 million public offering
We advised CureVac on the equity offering